ASTROGLIOMA

Clinical trials for ASTROGLIOMA explained in plain language.

Never miss a new study

Get alerted when new ASTROGLIOMA trials appear

Sign up with your email to follow new studies for ASTROGLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

New drug combo shows promise in brain tumor fight

Disease control Terminated

This study tested a new drug called zotiraciclib (TG02) combined with temozolomide (TMZ) in adults with recurrent brain tumors (anaplastic astrocytoma or glioblastoma). The goal was to find safe doses and see if the combo works better than TMZ alone. The study was stopped early, …

Matched conditions: ASTROGLIOMA

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 10, 2026 13:24 UTC

ASTROGLIOMA

Get alerted when new ASTROGLIOMA trials appear

New drug combo shows promise in brain tumor fight